The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

Wednesday, 04 April 2018
Addition of rivaroxaban to aspirin lowers major vascular events but increases major bleeding in patients with stable coronary artery disease. There was no significant increase in intracranial bleeding or other critical organ bleeding. There was also a significant net benefit in favour of rivaroxaban plus aspirin and deaths were reduced by 23%.
Thursday, 22 March 2018
Free of charge 2 day CPD approved GP programme chaired by Dr Matt Kearney.  Includes preventing heart attacks and strokes at scale, atrial fibrillation, hypertension, heart failure and heart valve disease.  Plus streams on diabetes, obesity, women’s health, dermatology, older people, end of life, 180 exhibitors and hands-on workshops.
Category: Editorial
Tuesday, 20 March 2018
In 2015 West Hampshire CCG (WHCCG) recognised that there was a significant burden of undiagnosed atrial fibrillation (AF), which was resulting in an excess of preventable strokes. This could be improved by the prescription of anticoagulation in those at increased risk. 
Category: Editorial
Topics covered:
Monday, 19 March 2018
Research from an observational study in 9000 patients presented at the recent Acute Cardiovascular Care 2018 congress found that heart attack patients prescribed antidepressants have a lower 1-year survival rate than those not on antidepressants. The study found that those prescribed antidepressants at discharge from hospital after a heart attack had a 66% greater risk of mortality one year later than patients not prescribed the drugs, although they noted the cause is not necessarily related directly to the antidepressants.
Monday, 19 March 2018
New research shows that the earlier a person is diagnosed with type 2 diabetes, the higher their risk of death from heart disease and stroke. In almost all countries of the world, diabetes rates are increasing substantially in younger adults, aged 20-45 years. This increase means there is a steadily growing pool of diabetes patients who are exposed to diabetes for a longer period in their lives.
Topics covered:
Monday, 19 March 2018
A fascinating new study from Sweden and Finland suggests that diabetes is actually five separate diseases and treatment could be tailored for each type. Study authors suggest these findings will usher in a new era of personalised medicine for diabetes.
Topics covered:
Tuesday, 27 February 2018
Chris Arden, Editor-in-chief of the Primary Care Cardiovascular Journal With New Year fading into the distance and the days getting longer, our attention focuses on what this year will bring in cardiovascular disease and diabetes.
Tuesday, 27 February 2018
The prevalence of previously undetected dysglycaemia is high in patients who are free from cardiovascular disease but have one or two other risk factors (hypertension and/or dyslipidaemia). A new study shows that using the FINDRISC questionnaire as a first step of dysglycaemia screening does not provide any benefit in this population.
Topics covered:
Tuesday, 27 February 2018
A recent study using data from the UK Paediatric Familial Hypercholesterolaemia Register shows that statin therapy reduces LDL cholesterol by 31% with no associated liver or muscle damage. Statin use in children is not associated with any reductions in growth rate and is safe in childhood, with no biochemical evidence of toxicity over a 2- to 3-year period.
Friday, 23 February 2018
Stories in this Evidence in Practice include: Health survey for England, 2016: The good and the bad news Healthy lifestyle changes have a long-term benefit for type 2 diabetes prevention Weight loss diets reduce the risk of premature death for people with obesity Very low calorie diet can achieve a remission of Type 2 Diabetes Dash diet plus sodium reduction lowers systolic blood pressure Long-term follow-up underscores benefits of lowering LDL-C in CVD primary prevention Blood pressure self-monitoring is more effective with professional support AF and other chronic conditions = higher risk of death Clinical trials underestimate the real-world impact of Atherosclerotic CVD The burden of heart failure continues to rise in the UK

Article search and filter